Núbia Boechat Selected Research

Chloroquine (Aralen)

11/2008	Synthesis, antimalarial activity, and intracellular targets of MEFAS, a new hybrid compound derived from mefloquine and artesunate.
3/2007	Enhanced activity of mefloquine and artesunic acid against Plasmodium falciparum in vitro and P. berghei in mice by combination with ciprofloxacin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Núbia Boechat Research Topics

Disease

3	Malaria 09/2014 - 03/2007
2	Chagas Disease (American Trypanosomiasis) 04/2022 - 01/2019
2	Parasitemia 11/2008 - 03/2007
1	Cytokine Release Syndrome 01/2021
1	COVID-19 01/2021
1	Cerebral Malaria 04/2016
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2016
1	Trypanosomiasis 06/2014
1	Infections 11/2008
1	Hepatocellular Carcinoma (Hepatoma) 11/2008
1	Tuberculosis (Tuberculoses) 12/2006

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 01/2021 - 12/2006
3	Antimalarials (Antimalarial Agents)IBA 09/2014 - 03/2007
2	NifurtimoxIBA 04/2022 - 01/2019
2	benzonidazole (benznidazole)IBA 04/2022 - 01/2019
2	Chloroquine (Aralen)FDA LinkGeneric 11/2008 - 03/2007
1	Antiviral Agents (Antivirals)IBA 01/2021
1	daclatasvirIBA 01/2021
1	SofosbuvirIBA 01/2021
1	PyrrolesIBA 04/2016
1	Atorvastatin (Lipitor)FDA Link 04/2016
1	efavirenz (Sustiva)FDA Link 01/2016
1	VaccinesIBA 09/2014
1	megazolIBA 06/2014
1	4-nitroimidazoleIBA 06/2014
1	HypoxanthineIBA 03/2007
1	artesunic acidIBA 03/2007
1	Ciprofloxacin (Cipro)FDA LinkGeneric 03/2007
1	Mefloquine (Lariam)FDA LinkGeneric 03/2007